<DOC>
	<DOCNO>NCT02877433</DOCNO>
	<brief_summary>This study aim compare clinical performance 4 mm short implant support cross-arch fixed reconstruction edentulous mandible either combination two short implant distal support two implant conventional length place interforaminal region , combination four short implant distal support two interforaminal implant conventional length .</brief_summary>
	<brief_title>4 mm Implants Fixed Cross-Arch Prostheses</brief_title>
	<detailed_description>This post-market , multi-center , prospective , open , randomize control clinical study . The total study duration patient 36 ± 2 month . Roxolid Standard Plus Implants , 4 mm , Ø 4.1 mm , SLActive place position 36/46 35/45 , 36/46 . Roxolid Standard Plus Implants , Ø 4.1 mm , SLActive , lengths 10 , 12 14 mm place position 33/43 . In total 10 visit per patient schedule study . Implant survival , implant success , prosthetic survival success , adverse event ( AEs ) assess . All product CE- ( Conformité Européenne , mean European Conformity ) mark use within intend use . Two center Switzerland Northern Ireland participate . The study amendment perform accord International Organization Standardization ( ISO ) 14155:2011 , local legal regulatory requirement conform Declaration Helsinki ( last revision Fortaleza 2013 )</detailed_description>
	<criteria>Males female least 18 year age ( include 18 year ) Subject must voluntarily sign informed consent , willing able attend schedule followup visit , agree encode data collect analyzed Fully edentulous ( late extraction mandible perform least 12 week implant placement ) restore complete denture Atrophic jaw bone posterior area , sufficient bone height width permit insertion four short implant , 4 mm region first molar second premolar side two standard length implant canine region Patients inadequate bone volume and/or quality Uncontrolled systemic disease would interfere dental implant therapy ( e.g . uncontrolled diabetes ) Any contraindication oral surgical procedure History local irradiation therapy head / neck area Patients smoke &gt; 10 cigarette per day tobacco equivalent , chew tobacco ≥ 20 pack year Medical condition require chronic high dose steroid therapy high dose antiresorptive treatment Subjects undergone administration investigational device within 30 day enrollment study Conditions circumstance , opinion investigator , would prevent completion study participation interfere analysis study result , history noncompliance unreliability Cognitive impairment would interfere ability perform adequate oral hygiene ( assessed Ottawa 3DY scale ) Patients chronic pain Patients HIV and/ Hepatitis infection Severe bruxing clench habit Patients inadequate oral hygiene unmotivated adequate home care ( Denture Plaque Index ( DPI ) ≥ 5 ) Patients drug alcohol abuse Patients allergies hypersensitivity chemical ingredient titaniumzirconium alloy Major simultaneous augmentation procedure . Dehiscence vertical distance 3 mm A woman pregnant planning become pregnant point study duration Secondary Patients inadequate bone volume and/or quality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Small diameter implant</keyword>
	<keyword>Cross-arch prosthesis</keyword>
</DOC>